ARCHIVES

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Henderson Committee Final Recommendation Made On P01s

February 10, 1984

House Passes Cancer Bill With Mandates for NCI

September 28, 2012

Avon 1995 Grant Application Available

December 2, 1994

M.D. Anderson, Madrid In Joint Program

September 2, 1988

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986

Bonadonna, Fisher Share %50,000 Bristol-Myers Award

April 23, 1993